三诺生物回购进展：已回购482.49万股，金额近1亿元

Group 1 - The company, Sanor Biotech Co., Ltd., has approved a share repurchase plan with a total fund allocation between 150 million to 300 million yuan, using its own funds and bank loans [1] - The initial maximum repurchase price was set at 34 yuan per share, which was later adjusted to 33.78 yuan per share after the annual equity distribution plan was completed [1] - As of August 31, 2025, the company has repurchased a total of 4.8249 million shares, accounting for 0.86% of the total share capital, with a total transaction amount of approximately 99.92 million yuan [1] Group 2 - The company has complied with relevant regulations during the repurchase process, ensuring that the timing, quantity, and price of the repurchase do not affect the securities trading price [2] - The company plans to continue the repurchase plan based on market conditions and will fulfill its information disclosure obligations in a timely manner [2]